Leveraging near-real-time patient and population data to incorporate fluctuating risk of severe COVID-19: development and prospective validation of a personalised risk prediction tool
Related Posts
Larson ME, Pan Y, Lakhani F, Chavez J, Santana A, Nogueira NF, Lieberman A, Riley ED, Wu KC, Tien P, Kizer J, Floris-Moore M, Pyslar[...]
Morinishi CD, Brown CE, Younes R. Invasive Cutaneous Mucormycosis in a Patient With Chronic Lymphocytic Leukemia on Obinutuzumab, Idelalisib, and Bruton Tyrosine Kinase Degrader: A[...]
Livorsi DJ, Merchant J, Cho H, Goetz MB, Alexander B, Goto M. Association between postdischarge antibiotic use and C. difficile testing as a surrogate for clinically significant[...]